During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 0.66 million, with the beta value of the company hitting 0.47. At the end
In the last trading session, 1.19 million shares of the Viridian Therapeutics Inc (NASDAQ:VRDN) were traded, and its beta was 0.47. Most recently the company’s
In last trading session, Viridian Therapeutics Inc (NASDAQ:VRDN) saw 0.52 million shares changing hands with its beta currently measuring 0.62. Company’s recent per share price
During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 1.87 million, with the beta value of the company hitting 0.63. At the end
In the last trading session, 1.7 million shares of the Viridian Therapeutics Inc (NASDAQ:VRDN) were traded, and its beta was 0.62. Most recently the company’s
In the last trading session, 1.12 million shares of the Viridian Therapeutics Inc (NASDAQ:VRDN) were traded, and its beta was 0.66. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
